- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Expanding Medicaid Through Section 1115 Waiver
An analysis of the Medicaid expansion plans of 6 states that have been granted Section 1115 waivers identified both the promise and limits that have emerged through these alternative expansion approaches.
The Section 1115 demonstration waiver allows states to tailor their Medicaid expansion plans to meet practical and political realities. An analysis of the Medicaid expansion plans of 6 states—Arkansas, Indiana, Iowa, Michigan, New Hampshire, and Pennsylvania—that have been granted the waivers identifies both the promise and limits that have emerged through these alternative expansion approaches.
States looking to expand Medicaid under Section 1115 must still demonstrate that the plan will be consistent with Medicaid objectives, specifically that it will extend coverage to low-income and vulnerable populations. While HHS can approve many of the changes under Section 1115, some need to be left up to Congress, experts wrote in a blog post for The Commonwealth Fund. There 3 specific areas of concern:
- Work requirements
- Higher premiums
- Low-income pools
Read more at The Commonwealth Fund: http://bit.ly/1dEUrSp
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
